Güçlü, M. Et Al. 2017. Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes Mellitus. 19th European Congress of Endocrinology 2017 , (Lisbon, Portugal).

Güçlü, M., KÜÇÜKSARAÇ KIYICI, D. S., GÜL, Z., & ÇAVUN, S., (2017). Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes Mellitus . 19th European Congress of Endocrinology 2017, Lisbon, Portugal

Güçlü, Metin Et Al. "Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes Mellitus," 19th European Congress of Endocrinology 2017, Lisbon, Portugal, 2017

Güçlü, Metin Et Al. "Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes Mellitus." 19th European Congress of Endocrinology 2017 , Lisbon, Portugal, 2017

Güçlü, M. Et Al. (2017) . "Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes Mellitus." 19th European Congress of Endocrinology 2017 , Lisbon, Portugal.

@conferencepaper{conferencepaper, author={Metin Güçlü Et Al. }, title={Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes Mellitus}, congress name={19th European Congress of Endocrinology 2017}, city={Lisbon}, country={Portugal}, year={2017}}